Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of cancer-related fibroblasts in bladder cancer and construction of CAFs-based bladder cancer classification: insights from single-cell and multi-omics analysis. | Front Immunol | 2025 | 41019085 | PubTator, text mining | PubMed |
| The role of GPI-anchored LY6/uPAR family proteins in connecting membrane microdomains with immune regulation and diseases. | Crit Rev Oncol Hematol | 2025 | 41016505 | PubTator, text mining | PubMed |
| Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobank. | Bladder Cancer | 2025 | 40978103 | PubTator, text mining | PubMed |
| Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors. | Front Oncol | 2025 | 40969260 | PubTator, text mining | PubMed |
| Spatial transcriptomics of intraductal carcinoma of the prostate. | Histopathology | 2025 | 40964799 | PubTator, text mining | PubMed |
| PSCA-CAR-NK cells exert cytotoxic activity against PSCA-expressing tumor cells and are characterized by a specific chemokine profile. | Cytotherapy | 2025 | 40944676 | PubTator, text mining | PubMed |
| Efficacy of Early Adolescent Skill for Emotions Intervention in Psychological Distress among Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Child Psychiatry Hum Dev | 2025 | 40824570 | PubTator, text mining | PubMed |
| IL-7 armed binary CAR T cell strategy to augment potency against solid tumors. | Front Immunol | 2025 | 40808942 | PubTator, text mining | PubMed |
| Association between the PSCA rs2976392 polymorphism and susceptibility to gastric cancer: a meta-analysis. | Front Genet | 2025 | 40741413 | PubTator, text mining | PubMed |
| Position and Dimension of the Inner Ear in Midterm Fetuses. | J Int Adv Otol | 2025 | 40522081 | PubTator, text mining | PubMed |
| The association between PSCA gene polymorphism and hepatocellular carcinoma risk. | World J Surg Oncol | 2025 | 40495136 | PubTator, text mining | PubMed |
| CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights. | Front Immunol | 2025 | 40463393 | PubTator, text mining | PubMed |
| Integrating analysis of multi-omics summary data identifies novel plasma protein biomarkers and drug targets for bladder cancer. | Discov Oncol | 2025 | 40316856 | PubTator, text mining | PubMed |
| Association of rs2294008 (PSCA) Gene polymorphism in Urothelial Bladder Cancer of South Indian Population. | Asian Pac J Cancer Prev | 2025 | 40302098 | PubTator, text mining | PubMed |
| Developing cell-based therapies for pancreatic ductal adenocarcinoma. | J Clin Invest | 2025 | 40231460 | PubTator, text mining | PubMed |
| Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice. | J Clin Invest | 2025 | 40231459 | PubTator, text mining | PubMed |
| Potential therapeutic targets for bladder cancer: a proteome-wide Mendelian randomization study. | Am J Cancer Res | 2025 | 40226474 | PubTator, text mining | PubMed |
| Targeting the tumour cell surface in advanced prostate cancer. | Nat Rev Urol | 2025 | 40169837 | PubTator, text mining | PubMed |
| Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors. | JCO Precis Oncol | 2025 | 40138603 | PubTator, text mining | PubMed |
| Correlation of GD2 Biosynthesis Enzymes With Cancer Stem Cell Markers in Human Breast Cancer. | Cancer Genomics Proteomics | 2025 | 39993803 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=3